Study of CMP-CPS-001 in Healthy Volunteers

Inclusion Criteria:

• Healthy adults 18 to 55 years inclusive at time of informed consent

• BMI ≥18.0 and ≤32 kg/m2 at screening, and ≤110 kg

• Willing and able to sign informed consent form

Exclusion Criteria:

• Any significant disease or disorder which, in the opinion of the Investigator, mayeither put the study participant at risk because of participation in the study, mayinfluence the results of the study, or may affect the study participant's ability toparticipate in the study

• Clinically relevant illness within 7 days before the first dose of study drug

• History of intolerance to subcutaneous injection or relevant abdominal scarring

• Laboratory results outside normal ranges at screening and judged as clinicallyrelevant by the Investigator for liver function, kidney function, and platelets

• Positive viral serology test results for human immunodeficiency virus type 1 or 2antibodies, hepatitis B surface antigen or hepatitis C virus antibody

• Any other safety laboratory result considered clinically significant andunacceptable by the Investigator